Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$16.22
-4.8%
$18.16
$5.55
$21.00
$719.26M1.02425,752 shs496,207 shs
Envista Holdings Co. stock logo
NVST
Envista
$15.47
-3.9%
$19.18
$14.79
$23.00
$2.66B1.122.45 million shs5.80 million shs
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$51.23
-6.5%
$63.77
$45.68
$103.81
$2.81B1.05762,637 shs1.43 million shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$67.48
-6.5%
$51.19
$36.61
$74.00
$3.09B-2.29670,666 shs1.27 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
-3.67%-10.27%-8.49%+5.77%+111.41%
Envista Holdings Co. stock logo
NVST
Envista
-7.98%-10.70%-13.44%-15.42%-20.48%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-5.13%-11.30%-15.70%-35.02%+17.68%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-2.05%+7.08%+62.38%+55.32%+72.80%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AxoGen, Inc. stock logo
AXGN
AxoGen
3.4859 of 5 stars
3.55.00.00.03.52.50.6
Envista Holdings Co. stock logo
NVST
Envista
4.704 of 5 stars
4.04.00.03.93.60.02.5
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.6553 of 5 stars
3.41.00.00.03.63.30.6
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.5567 of 5 stars
4.61.00.04.63.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
3.00
Buy$22.6039.33% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.07
Hold$20.1830.44% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$94.2984.04% Upside
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.22
Buy$99.6347.64% Upside

Current Analyst Ratings Breakdown

Latest AXGN, SLNO, PRCT, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$70.00 ➝ $100.00
3/28/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$70.00 ➝ $81.00
3/28/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $108.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$105.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Laidlaw
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $105.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$67.00 ➝ $123.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$72.00 ➝ $102.00
3/17/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
3/10/2025
Envista Holdings Co. stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$23.00 ➝ $21.00
3/8/2025
Envista Holdings Co. stock logo
NVST
Envista
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$19.00
3/6/2025
Envista Holdings Co. stock logo
NVST
Envista
New Street Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$19.00
(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$187.34M3.84N/AN/A$2.22 per share7.31
Envista Holdings Co. stock logo
NVST
Envista
$2.51B1.06$1.20 per share12.91$17.04 per share0.91
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$224.50M12.51N/AN/A$5.56 per share9.21
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.16 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$21.72M-$0.22N/AN/AN/A-7.91%-14.91%-7.49%5/1/2025 (Estimated)
Envista Holdings Co. stock logo
NVST
Envista
-$1.12B-$6.49N/A12.791.27-44.56%3.86%2.21%4/29/2025 (Estimated)
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$1.76N/AN/AN/A-50.07%-38.57%-26.06%5/7/2025 (Estimated)
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$38.99M-$4.26N/AN/AN/AN/A-61.99%-55.21%5/8/2025 (Estimated)

Latest AXGN, SLNO, PRCT, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025N/A
AxoGen, Inc. stock logo
AXGN
AxoGen
-$0.01N/AN/AN/A$48.35 millionN/A
3/5/2025Q4 2024
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.86-$1.27-$0.41-$1.27N/AN/A
2/25/2025Q4 2024
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.34-$0.35-$0.01-$0.35$66.79 million$68.24 million
2/5/2025Q4 2024
Envista Holdings Co. stock logo
NVST
Envista
$0.23$0.24+$0.01$0.01$646.28 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.67
3.74
2.47
Envista Holdings Co. stock logo
NVST
Envista
0.44
2.04
1.76
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.21
6.02
5.07
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/A
17.26
17.26

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Envista Holdings Co. stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
7.00%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
17.40%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
12.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45044.34 million40.93 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,700172.19 million169.95 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
43054.82 million43.10 millionOptionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3045.86 million37.81 millionOptionable

Recent News About These Companies

HC Wainwright Issues Optimistic Estimate for SLNO Earnings
Soleno Therapeutics price target raised to $100 from $70 at H.C. Wainwright
SLNO FY2025 EPS Forecast Reduced by Cantor Fitzgerald
Q1 EPS Forecast for Soleno Therapeutics Decreased by Analyst

New MarketBeat Followers Over Time

Media Sentiment Over Time

AxoGen stock logo

AxoGen NASDAQ:AXGN

$16.22 -0.82 (-4.81%)
Closing price 04:00 PM Eastern
Extended Trading
$16.72 +0.50 (+3.05%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Envista stock logo

Envista NYSE:NVST

$15.47 -0.63 (-3.91%)
Closing price 03:59 PM Eastern
Extended Trading
$15.48 +0.01 (+0.10%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$51.23 -3.55 (-6.48%)
Closing price 04:00 PM Eastern
Extended Trading
$51.24 +0.01 (+0.02%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$67.48 -4.68 (-6.49%)
Closing price 04:00 PM Eastern
Extended Trading
$67.53 +0.05 (+0.07%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.